Nixon Peabody advises in veterinary cancer practice acquisition



September 16, 2015

Increased interest by consumers and investors driving market activity

Media Relations Director
Allison McClain
amcclain@nixonpeabody.com
617-345-1128

Los Angeles, CA. Protecting the health of a companion animal is a top concern among Americans. According to the Center for Cancer Research, there are 65 million dogs and 32 million cats in the United States. Of these, roughly 6 million new cancer diagnoses are made in dogs and a similar number made in cats each year.

PetCure Oncology, the largest provider of stereotactic radiosurgery (SRS) in the veterinary market, is adding to its network with the acquisition of Veterinary MRI and Radiotherapy Center (VRIC) of NJ, a pioneer in providing leading-edge cancer care and imaging services to the region’s companion animals.

VRIC was the first freestanding imaging and radiation treatment center in the world when it opened to the public in 2002. As part of the PetCure network, the practice will still be dedicated to its mission to improve the lives of companion animals by providing the most advanced radiation therapy and imaging services including CT and MRI.

Now, as part of PetCure’s network, VRIC joins other veterinary radiosurgery centers with locations in Phoenix and Cincinnati. Centers in Wisconsin and Illinois are set to open in the coming months.

Nixon Peabody advised PetCure on this matter. The team was led by health services partner Jill Gordon and included health care associates Jennifer Cormano and Daniel Eliav and real estate partner Kris Curran.

Back to top